Ihsan Ullah  博士

办公地址：广州国际校区C1-c805  电子邮件:ihsanullah@scut.edu.cn

2024-至今  华南理工大学生物医学科学与工程学院  博士后

2020-2023  黑龙江中医药大学生药学  博士

2016-2018  Hazara University (Pakistan)人类遗传学  哲学硕士(M.Phil)

2012-2014  Hazara University (Pakistan)生物化学  硕士 (MSc)

2010-2012  University of Swat (Pakistan)理学学士 (BSc)

研究方向

癌症免疫治疗与药物递送

主要从事博士研究方向为癌症代谢组学，当前重点聚焦于Nano-PROTACs在癌症免疫治疗及糖尿病创面修复中的应用研究。以第一作者/共同第一作者身份在Cancers、Frontiers in Oncology等期刊发表论文4篇。

个人代表论文

1.Ullah, I., Yang, L., Yin, F. T., Sun, Y.,Li, X. H., Li, J., & Wang, X. J. (2022). Multi-omics approaches incolorectal cancer screening and diagnosis, recent updates and futureperspectives. Cancers, 14(22), 5545.

2.Xiao, K., Li, X., Ullah, I., Hu, W., Wang, K., Yang, F.,... & Li, X. (2025). Unveiling the role of ASPP1 in cancer progression:pan-cancer bioinformatics and experimental validation in colorectal cancer.Frontiers in Oncology, 14, 1529809.

3.Xiao, K., Ullah, I., Yang, F., Wang, J., Hou, C., Liu,Y., & Li, X. (2023). Comprehensive bioinformatics analysis of FXR1 acrosspan-cancer: Unraveling its diagnostic, prognostic, and immunologicalsignificance. Medicine, 102(48), e36456.

4. Li, X., Ullah, I., Hou, C., Liu, Y.,& Xiao, K. (2023). Network pharmacology and molecular docking study on thetreatment of polycystic ovary syndrome with angelica sinensis-radix rehmanniaedrug pair. Medicine, 102(46), e36118.